Skip to main content

Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.

Publication ,  Journal Article
Wikstrand, CJ; Fredman, P; McLendon, RR; Svennerholm, L; Bigner, DD
Published in: Mol Chem Neuropathol
1994

A library of epitope-defined antiganglioside monoclonal antibodies has been used to analyze the ganglioside phenotype of human glioma cell lines, rodent xenografts derived from them, and a separate panel of human glioma biopsies by multiple quantitative and qualitative assays. We have shown that the ganglioside phenotypes of cultured cell lines differ from the ganglioside phenotypes in the xenografts grown from the parent lines. The lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 are expressed in the majority of primary human central nervous system neoplasms and xenografts derived from glioma cell lines, whereas glioma cell lines themselves express 3'-isoLM1 and 3',6'-isoLD1 in only 2/15 and 0/15 cases, respectively. Examination of the ganglioside profiles of serially passaged xenografts established from the glioma cell line D-54 MG, which does not express the lacto series, revealed the appearance of these gangliosides within one to two passages in vivo. The presence of these defined gangliosides in the majority of human gliomas and their absence in normal brain supports their application in compartmental therapy of primary central nervous system tumors.

Duke Scholars

Published In

Mol Chem Neuropathol

DOI

ISSN

1044-7393

Publication Date

1994

Volume

21

Issue

2-3

Start / End Page

129 / 138

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Transplantation, Heterologous
  • Phenotype
  • Neurology & Neurosurgery
  • Molecular Sequence Data
  • Mice, Nude
  • Mice
  • Humans
  • Glioma
  • Gangliosides
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wikstrand, C. J., Fredman, P., McLendon, R. R., Svennerholm, L., & Bigner, D. D. (1994). Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro. Mol Chem Neuropathol, 21(2–3), 129–138. https://doi.org/10.1007/BF02815347
Wikstrand, C. J., P. Fredman, R. R. McLendon, L. Svennerholm, and D. D. Bigner. “Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.Mol Chem Neuropathol 21, no. 2–3 (1994): 129–38. https://doi.org/10.1007/BF02815347.
Wikstrand CJ, Fredman P, McLendon RR, Svennerholm L, Bigner DD. Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro. Mol Chem Neuropathol. 1994;21(2–3):129–38.
Wikstrand, C. J., et al. “Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.Mol Chem Neuropathol, vol. 21, no. 2–3, 1994, pp. 129–38. Pubmed, doi:10.1007/BF02815347.
Wikstrand CJ, Fredman P, McLendon RR, Svennerholm L, Bigner DD. Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro. Mol Chem Neuropathol. 1994;21(2–3):129–138.

Published In

Mol Chem Neuropathol

DOI

ISSN

1044-7393

Publication Date

1994

Volume

21

Issue

2-3

Start / End Page

129 / 138

Location

United States

Related Subject Headings

  • Tumor Cells, Cultured
  • Transplantation, Heterologous
  • Phenotype
  • Neurology & Neurosurgery
  • Molecular Sequence Data
  • Mice, Nude
  • Mice
  • Humans
  • Glioma
  • Gangliosides